Feedback / Questions
NJA-730 - NapaJen Pharma
https://www.globenewswire.com/news-release/2020/10/08/2105503/0/en/NapaJen-Pharma-Reports-Positive-Results-from-Phase-1-Clinical-Trial-of-Novel-RNA-Interference-RNAi-Therapeutic.html
Oct 8, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious